Business Standard

Medicamen Biotech consolidated net profit declines 18.21% in the December 2020 quarter

Image

Capital Market

Sales decline 6.82% to Rs 32.92 crore

Net profit of Medicamen Biotech declined 18.21% to Rs 3.01 crore in the quarter ended December 2020 as against Rs 3.68 crore during the previous quarter ended December 2019. Sales declined 6.82% to Rs 32.92 crore in the quarter ended December 2020 as against Rs 35.33 crore during the previous quarter ended December 2019. ParticularsQuarter EndedDec. 2020Dec. 2019% Var.Sales32.9235.33 -7 OPM %15.9815.40 -PBDT5.175.70 -9 PBT4.455.06 -12 NP3.013.68 -18

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 13 2021 | 8:07 AM IST

Explore News